Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
03/2005
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1599726A Pyrimidine compounds
03/23/2005CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
03/23/2005CN1599722A 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
03/23/2005CN1599717A Cyclic diamine compounds having fused-ring groups
03/23/2005CN1599607A Carbinols for the treatment of neuropathic dysfunction
03/23/2005CN1598700A Organophotoreceptor with an epoxy-modified charge transport compound having an azine group
03/23/2005CN1597680A New method of synthesizing thalidomide and its derivative
03/23/2005CN1597677A Compounds and methods for modulation of estrogen receptors
03/23/2005CN1597667A Quinazoline derivatives as angiogenesis inhibitors
03/23/2005CN1193996C Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent
03/22/2005US6870053 Useful in treatment or prophylaxis of viral infections, for example, human immunodeficiency virus and hepatitis B virus
03/22/2005US6869974 Pharmaceutical compounds
03/22/2005US6869965 Such as 2-methylpropyl-(4-bromo-3-fluorophenyl)carbamate
03/22/2005US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
03/22/2005US6869950 Such as 1-(2-chloro-4-(n-octyloxy)benzyl)-2-methyl-6-(1-pentane -sulfonylcarbamoyl)benzimidazole
03/22/2005US6869943 Sorbitol dehydrogenase inhibitors
03/22/2005US6869913 Pyridazin-3-one derivatives, their use and intermediates for their production
03/22/2005US6869605 Anticarcinogenic agents
03/17/2005WO2005023799A1 Fused bicyclic carboxamide derivatives and methods of their use
03/17/2005WO2005023773A1 Process for the preparation of substituted aryl pyrazoles
03/17/2005WO2005023251A1 N3 alkylated benzimidazole derivatives as mek inhibitors
03/17/2005WO2005023246A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
03/17/2005WO2005023242A1 Entry inhibitors of the hiv virus
03/17/2005WO2005005415A8 Indoles useful in the treatment of inflammation
03/17/2005WO2005000817A3 Diphenylpyridine derivatives, preparation and therapeutic application thereof
03/17/2005WO2004106315A3 4-amino-2(5h)-furanones useful as cholecystokinin antagonists
03/17/2005WO2004092196A3 Tie-2 modulators and methods of use
03/17/2005WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
03/17/2005WO2004072033A3 Pyrazoles and methods of making and using the same
03/17/2005WO2003045918A8 Piperidine-based mch antagonists for treatment of obesity and cns disorders
03/17/2005WO2003037887A8 Therapeutic isoquinoline compounds
03/17/2005WO2002072571A8 Pyridinyl pyrazoles useful for the treatment of copd
03/17/2005US20050059733 and stilbene oxides; 3,5-dihydroxy-4-isopropylstilbene for example; treating various immune, inflammatory, and autoimmune diseases
03/17/2005US20050059729 Substituted cyclic compounds
03/17/2005US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example
03/17/2005US20050059722 Kinase inhibitors, such as focal adhesion kinase (FAK) inhibitors; treating cancer; 2-methylsulfonyl-N-(3-thiophen-2-yl-1H-indazol-5-yl)benzenesulfonamide for example
03/17/2005US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor
03/17/2005US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma
03/17/2005US20050059687 Modulators of ATP-Binding Cassette transporters
03/17/2005US20050059678 such as (E)-N-{4-[4-(benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide used as antineoplastic agents, or inhibitors of the HER-2 gene or proteins and epidermal growth factor receptor enzymes
03/17/2005US20050059676 Cyclic pyrazinoylguanidine sodium channel blockers
03/17/2005US20050059673 serotonin receptor antagonists such as 8-{4-[2-(1-benzofuran-3-yl)ethyl]-1-piperazinyl}-6-fluoroquinoline, used for treatment and/or prevention of depression, anxiety and cognitive deficits arising from Alzheimer's disease, neurodegenerative disorders, schizophrenia and prostate cancer
03/17/2005US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
03/17/2005US20050059663 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
03/17/2005US20050059662 Substituted quinazolinone compounds
03/17/2005US20050059585 Methionine aminopeptidase-2 inhibitors and methods of use thereof
03/17/2005US20050058635 Anticancer agents; therapy for infections; administering glutaminyl cyclase inhibitor; Alzheimer's disease; Down syndrome; controlling fertility; schizophrenia; skin disorders
03/17/2005DE10337942A1 Aminobenzimidazolderivate Aminobenzimidazolderivate
03/17/2005CA2537098A1 N3 alkylated benzimidazole derivatives as mek inhibitors
03/17/2005CA2537097A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
03/16/2005EP1514871A1 Dispiro 1,2,4 - trioxolane antimalarials
03/16/2005EP1514870A1 Prodrug and process for producing the same
03/16/2005EP1513833A1 Novel 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same
03/16/2005EP1513827A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
03/16/2005EP1513821A1 Protein kinase inhibitors
03/16/2005EP1513814A1 Novel piperidine compound
03/16/2005EP1513811A1 Non-peptidic brs-3 agonists
03/16/2005EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
03/16/2005EP1513530A1 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
03/16/2005EP1513527A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
03/16/2005EP1513520A2 Substituted pyrrolines as kinase inhibitors
03/16/2005EP1355903B1 Pyrazole derivatives against tgf overexpression
03/16/2005EP1250047B1 Herbicidal composition
03/16/2005EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/16/2005EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
03/16/2005CN1596251A Piperazine derivatives having SST1 antagonistic activity
03/16/2005CN1596247A Lactam derivatives as antagonists for human 11CBY receptors
03/16/2005CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer
03/16/2005CN1193028C Dual molecules containing peroxide derivative; synthesis and therapeutic applications thereof
03/16/2005CN1193027C Substituted pyrroles
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/16/2005CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005US6867230 Antibacterial and antiprotozoal agents
03/15/2005US6867227 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind the DNA minor groove as a dimer
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867221 Cyclic amine compounds and pharmaceutical composition containing the same
03/15/2005US6867206 6-carboxyphenyldihydropyridazinone derivatives and use thereof
03/15/2005US6867205 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance
03/15/2005US6867201 For therapy of abnormal cell growth, such as cancer, in mammals
03/15/2005US6867200 Anticancer agents; anticoagulants
03/15/2005CA2323047C Prodrugs of benzofuranylmethyl carbamate nk, antagonists
03/15/2005CA2146852C New substituted pyrazole derivatives, processes for their preparation and their use as herbicides
03/10/2005WO2005021539A1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity
03/10/2005WO2005021538A1 Novel chelating agents and chelates and their use
03/10/2005WO2005021531A1 N-substituted benzimidazolyl c-kit inhibitors
03/10/2005WO2005021529A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
03/10/2005WO2005021509A1 Quinoline derivatives as neutrophil elastase inhibitors and their use
03/10/2005WO2005021501A1 Minimally invasive physiological function monitoring agents
03/10/2005WO2005021500A1 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005WO2005020985A1 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2005020882A2 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005WO2004112793B1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
03/10/2005WO2004096795A3 C-fms kinase inhibitors
03/10/2005WO2004087673B1 Migrastatin analogs and uses thereof
03/10/2005WO2004071447B1 Substituted azole derivatives as therapeutic agents
03/10/2005WO2002080150A8 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness
03/10/2005US20050054721 3-Aryl-4-Hydroxyfuranone compounds and the human and animal health use thereof
1 ... 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 ... 694